Shanghai Haohai Biological Technology Co. Ltd

Research Shanghai Haohai Biological Technology Co. Ltd (5HB) on Bullrun: valuation model: 5.1% undervalued, market cap EUR 398.22M, P/E 12.6, dividend yield 7.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker5HB
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Valuation signal5.1% undervalued
• Market capEUR 398.22M
• P/E12.6
• Dividend yield7.3%
• Financial periodFY2025
• RevenueEUR 2.45B
• Revenue growth-8.7%
• Net incomeEUR 251.01M
• Free cash flowEUR 304.04M
• Gross margin70.0%

Valuation Snapshot

Bullrun's latest valuation model marks Shanghai Haohai Biological Technology Co. Ltd as 5.1% undervalued; latest market cap is EUR 398.22M; P/E is 12.6; dividend yield is 7.3%.

About Shanghai Haohai Biological Technology Co. Ltd

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan;

Frequently asked questions

Is Shanghai Haohai Biological Technology Co. Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Shanghai Haohai Biological Technology Co. Ltd as 5.1% undervalued.

What is Shanghai Haohai Biological Technology Co. Ltd's market cap?

Shanghai Haohai Biological Technology Co. Ltd's market capitalization is EUR 398.22M.

What is Shanghai Haohai Biological Technology Co. Ltd's P/E ratio?

Shanghai Haohai Biological Technology Co. Ltd's price-to-earnings (P/E) ratio is 12.6.

Does Shanghai Haohai Biological Technology Co. Ltd pay a dividend?

Shanghai Haohai Biological Technology Co. Ltd has a dividend yield of 7.3%.

What does Shanghai Haohai Biological Technology Co. Ltd do?

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices;